Type 2 diabetes and mental ill-health co-morbidity
Research type
Research Study
Full title
Exploring the Impact of Mental Ill Health on Medication Adherence Behaviour in Patients Diagnosed with Type 2 Diabetes
IRAS ID
265180
Contact name
Hana Morrissey
Contact email
Sponsor organisation
University of Wolverhampton, Institute of Human Sciences
Clinicaltrials.gov Identifier
n/a, n/a
Duration of Study in the UK
1 years, 5 months, 28 days
Research summary
The prevalence of mental ill health in the general population (1 in every 4 adults) is expected to be the same in special populations such as patients diagnosed with Type 2 diabetes. Studies shown that long-term conditions are associated with patients experiencing mental ill health problems or disorders and also with poor adherence to therapy as part of loss of motivation for self-care. This may be caused by the life-long treatment commitment and poor self-emotional awareness due to the mental disorders.
In this study we are aiming to screen patients diagnosed with type 2 diabetes for anxiety and depression to identify those who have both diabetes and one or both of depression and anxiety. We will, after reviewing their medication, identify the level of their diabetes control and if they have any adherence to therapy problems. We will identify the cause of the non-adherence (intentional or non-intentional), we will manage medications issues and refer for further assessment and treatment for mental illness (as applicable) and offer information about their medication and medical conditions to empower them and facilitate self-care. We will then follow the enrolled patients up for 6 months to explore if by improving patients’ mental health, their diabetes control can improve as adherence behaviour change.
This study is designed as a cohort observational study. The recruitment will be from one site and the activities are undertaken by the independent prescriber who is employed at the clinic, and is the enrolled patients' direct healthcare provider.
Patients will receive the information about the study and consent forms in the mail, posted by the practice administration staff. Verbal explanation by the researcher if they contacted here after receiving the study pack. Patients who return the participants' signed consent to participate form will be contacted by the researcher to arrange the consultation/s time and date.REC name
North West - Liverpool Central Research Ethics Committee
REC reference
19/NW/0508
Date of REC Opinion
9 Sep 2019
REC opinion
Further Information Favourable Opinion